Thus, the inhibition of MSCs’ interaction with AML cells after CXCL12/CXCR4, CD44, ITG4 or E-selectin inhibition reduces the resistance of leukemic cells to chemotherapy [260,261,262,263,264,265]. Here, CD44 is linked to acute myeloid leukemia.